DRDO-Developed Technology Behind Critical Drug Approved By DCGI For Radiological And Nuclear Emergencies swarajyamag.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from swarajyamag.com Daily Mail and Mail on Sunday newspapers.
Dr Reddy s Laboratories last year announced the commercial launch of 2-deoxy-D-glucose (2DG) for treatment of Covid-19. 2DG was developed by the Institute of Nuclear Medicine & Allied Sciences (INMAS), a laboratory of the Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddy s Laboratories (DRL), Hyderabad.Now,
Dr Reddy s Laboratories last year announced the commercial launch of 2-deoxy-D-glucose (2DG) for treatment of Covid-19. 2DG was developed by the Institute of Nuclear Medicine & Allied Sciences (INMAS), a laboratory of the Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddy s Laboratories (DRL), Hyderabad.Now,
A team of US researchers has identified how a specific protein in coronavirus damages heart tissue and they used a drug, currently in emergency use for the treatment of Covid in India, to reverse the toxic effects of that protein on the .